MINDERUNG DER TOXISCHEN EFFEKTE DES CARBOPLATINS DURCH VERWENDUNG VON DITHIOETHERN

To reduce the toxic effect of carboplatin, particularly myelosuppression and emesis, a dithioether having the formula (I) R1-(CH2)n-S-S-(CH2)m-R2 wherein each of R1 and R2 individually is SO3H or PO3H2; and each of m and n is individually 1, 2, 3 or 4; or a pharmaceutically acceptable salt thereof,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HAUSHEER, HERMAN, REDDY, GAURAVARAM, MURALI, DHANABALAN, HARIDAS, KOCHAT, SEETHARAMULU, PEDDAIAHGARI
Format:	Patent
Sprache:	ger
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	HAUSHEER, HERMAN REDDY, GAURAVARAM MURALI, DHANABALAN HARIDAS, KOCHAT SEETHARAMULU, PEDDAIAHGARI
description	To reduce the toxic effect of carboplatin, particularly myelosuppression and emesis, a dithioether having the formula (I) R1-(CH2)n-S-S-(CH2)m-R2 wherein each of R1 and R2 individually is SO3H or PO3H2; and each of m and n is individually 1, 2, 3 or 4; or a pharmaceutically acceptable salt thereof, preferably disodium 2,2'-dithiobis(ethane sulfonate) (dimesna), is administered in combination with carboplatin to a patient, at substantially the same time or sequentially, whereby the dithioether and the carboplatin become copresent in the blood of the patient. Compositions comprising carboplatin and the dithioether are included in the invention.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DE69709404TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DE69709404TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DE69709404TT23</originalsourceid><addsrcrecordid>eNqNi0EKwjAQAHPxIOoflt6FokXpsSYbE9SNbLbVWykST6KF-n-s4AM8DQwzU8UnTwa5pj2MAAlXH7VDArQWD4KjjaAr3oXzsRJPEUzN2kGDfEEy368JBMaL8wHFIdNcTe7dY0iLH2cqsyjaLVP_atPQd7f0TO_W4Kbc5mWRFyKr9V_RB1aKMLE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MINDERUNG DER TOXISCHEN EFFEKTE DES CARBOPLATINS DURCH VERWENDUNG VON DITHIOETHERN</title><source>esp@cenet</source><creator>HAUSHEER, HERMAN ; REDDY, GAURAVARAM ; MURALI, DHANABALAN ; HARIDAS, KOCHAT ; SEETHARAMULU, PEDDAIAHGARI</creator><creatorcontrib>HAUSHEER, HERMAN ; REDDY, GAURAVARAM ; MURALI, DHANABALAN ; HARIDAS, KOCHAT ; SEETHARAMULU, PEDDAIAHGARI</creatorcontrib><description>To reduce the toxic effect of carboplatin, particularly myelosuppression and emesis, a dithioether having the formula (I) R1-(CH2)n-S-S-(CH2)m-R2 wherein each of R1 and R2 individually is SO3H or PO3H2; and each of m and n is individually 1, 2, 3 or 4; or a pharmaceutically acceptable salt thereof, preferably disodium 2,2'-dithiobis(ethane sulfonate) (dimesna), is administered in combination with carboplatin to a patient, at substantially the same time or sequentially, whereby the dithioether and the carboplatin become copresent in the blood of the patient. Compositions comprising carboplatin and the dithioether are included in the invention.</description><edition>7</edition><language>ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020529&DB=EPODOC&CC=DE&NR=69709404T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020529&DB=EPODOC&CC=DE&NR=69709404T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HAUSHEER, HERMAN</creatorcontrib><creatorcontrib>REDDY, GAURAVARAM</creatorcontrib><creatorcontrib>MURALI, DHANABALAN</creatorcontrib><creatorcontrib>HARIDAS, KOCHAT</creatorcontrib><creatorcontrib>SEETHARAMULU, PEDDAIAHGARI</creatorcontrib><title>MINDERUNG DER TOXISCHEN EFFEKTE DES CARBOPLATINS DURCH VERWENDUNG VON DITHIOETHERN</title><description>To reduce the toxic effect of carboplatin, particularly myelosuppression and emesis, a dithioether having the formula (I) R1-(CH2)n-S-S-(CH2)m-R2 wherein each of R1 and R2 individually is SO3H or PO3H2; and each of m and n is individually 1, 2, 3 or 4; or a pharmaceutically acceptable salt thereof, preferably disodium 2,2'-dithiobis(ethane sulfonate) (dimesna), is administered in combination with carboplatin to a patient, at substantially the same time or sequentially, whereby the dithioether and the carboplatin become copresent in the blood of the patient. Compositions comprising carboplatin and the dithioether are included in the invention.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi0EKwjAQAHPxIOoflt6FokXpsSYbE9SNbLbVWykST6KF-n-s4AM8DQwzU8UnTwa5pj2MAAlXH7VDArQWD4KjjaAr3oXzsRJPEUzN2kGDfEEy368JBMaL8wHFIdNcTe7dY0iLH2cqsyjaLVP_atPQd7f0TO_W4Kbc5mWRFyKr9V_RB1aKMLE</recordid><startdate>20020529</startdate><enddate>20020529</enddate><creator>HAUSHEER, HERMAN</creator><creator>REDDY, GAURAVARAM</creator><creator>MURALI, DHANABALAN</creator><creator>HARIDAS, KOCHAT</creator><creator>SEETHARAMULU, PEDDAIAHGARI</creator><scope>EVB</scope></search><sort><creationdate>20020529</creationdate><title>MINDERUNG DER TOXISCHEN EFFEKTE DES CARBOPLATINS DURCH VERWENDUNG VON DITHIOETHERN</title><author>HAUSHEER, HERMAN ; REDDY, GAURAVARAM ; MURALI, DHANABALAN ; HARIDAS, KOCHAT ; SEETHARAMULU, PEDDAIAHGARI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DE69709404TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2002</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HAUSHEER, HERMAN</creatorcontrib><creatorcontrib>REDDY, GAURAVARAM</creatorcontrib><creatorcontrib>MURALI, DHANABALAN</creatorcontrib><creatorcontrib>HARIDAS, KOCHAT</creatorcontrib><creatorcontrib>SEETHARAMULU, PEDDAIAHGARI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HAUSHEER, HERMAN</au><au>REDDY, GAURAVARAM</au><au>MURALI, DHANABALAN</au><au>HARIDAS, KOCHAT</au><au>SEETHARAMULU, PEDDAIAHGARI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MINDERUNG DER TOXISCHEN EFFEKTE DES CARBOPLATINS DURCH VERWENDUNG VON DITHIOETHERN</title><date>2002-05-29</date><risdate>2002</risdate><abstract>To reduce the toxic effect of carboplatin, particularly myelosuppression and emesis, a dithioether having the formula (I) R1-(CH2)n-S-S-(CH2)m-R2 wherein each of R1 and R2 individually is SO3H or PO3H2; and each of m and n is individually 1, 2, 3 or 4; or a pharmaceutically acceptable salt thereof, preferably disodium 2,2'-dithiobis(ethane sulfonate) (dimesna), is administered in combination with carboplatin to a patient, at substantially the same time or sequentially, whereby the dithioether and the carboplatin become copresent in the blood of the patient. Compositions comprising carboplatin and the dithioether are included in the invention.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	ger
recordid	cdi_epo_espacenet_DE69709404TT2
source	esp@cenet
subjects	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	MINDERUNG DER TOXISCHEN EFFEKTE DES CARBOPLATINS DURCH VERWENDUNG VON DITHIOETHERN
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T00%3A34%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HAUSHEER,%20HERMAN&rft.date=2002-05-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDE69709404TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true